Author: jsl8f@virginia.edu

VirginiaCancerRx Symposium was a success

This May the Virginia Drug Discovery Consortium held its second meeting entitled VirginiaCancerRx. Modeled after last year's well attended VirginiaBrainRx Symposium, the meeting included four keynote speakers and investigators from…

VIrginiaCancerRx Symposium

The second annual meeting of the Virginia Drug Discovery Consortium was held at Charlottesville, VA on May 30-31, 2017.  More than 120 people attended. Go to /www.newsplex.com/content/news/UVA-hosted-a-Cancer-Symposium-to-collaborate-on-new-treatments-425373794.html

Beth Sharlow reviews the values of drug repurposing

In the December issue of Assay and Drug Development Technologies (volume 14, pages 554-556, DOI: 10.1089/adt.2016.766), Beth Sharlow authored a paper entitled Revisiting Repurposing, which reviews the value of screening…

Graduate student Sumera Noreen departs

We were delighted to have Sumera Noreen, who is a graduate student at the Institute of Chemistry at the University of the Punjab in Lahore Pakistan, visit with us for…

Kelley McQueeney wins 2016 ASPET Travel Award

Graduate student Kelley McQueeney received a travel award for the 2016 Experimental Biology meeting in San Diego from the American Society for Pharmacology and Experimental Therapeutics. Congratulations Kelley.

Cancer Research is Not Rocket Science: It is Even Harder

President Obama made a surprising announcement at his State of the Union address this year: A moonshot program against cancer headed by Vice President Biden.  I must admit a feeling…

Kelley McQueeney wins the 2015 Robert Haynes Award

Congratulations to Kelley for winning the 2015 Department of Pharmacology Robert Haynes Award

New Cure Alzheimer’s Fund Grant

We are excited to announce that we were recently awarded a new grant with George Bloom (Biology and Cell Biology) to seek new drugs for the treatment of Alzheimer's Disease.

The Ethics of Ethical Drugs

  Several weeks ago, I was talking to the University of Virginia’s Chair of Pharmacology, Doug Bayliss, about the cost of discovering new drugs and their ultimate cost to patients.…